Business
Moderna shares Covid-19 vaccine trial blueprints, Pfizer follows – Bangkok Post
WASHINGTON: US biotech firm Moderna, one of nine companies in the late stages of clinical trials for a Covid-19 vaccine, became the first to publish the complete blueprints of its study following calls for greater transparency.
WASHINGTON: US biotech firm Moderna, one of nine companies in the late stages of clinical trials for a Covid-19 vaccine, became the first to publish the complete blueprints of its study following calls for greater transparency.
Pfizer, the other American company currently carrying out Phase 3 trials in the US, followed suit a short time later and there is now added pressure for the remainder to do the same.
Phase 3 is the final stage before approval, in which a vaccine and a placebo are tested…
Continue Reading
